NCT02450708 Selection of Allogeneic Hematopoietic Cell Donors Based on KIR and HLA Genotypes Status ACTIVE_NOT_RECRUITING Phase NA
NCT02338479 Natural History and Biology of Long-Term Late Effects Following Hematopoietic Cell Transplant for Childhood Hematologic Malignancies Status UNKNOWN Phase N/A
NCT02338050 Moxetumomab Pasudotox (CAT-8015, HA22) in Children With B-lineage Acute Lymphoblastic Leukemia and Minimal Residual Disease Prior to Allogeneic Hematopoietic Stem Cell Transplantation Status TERMINATED Phase PHASE2
NCT02200133 Randomized Study of Individualized Care Plans for Hematopoietic Cell Transplant Survivors Status COMPLETED Phase NA
NCT01772953 Treosulfan/Fludarabine/Low Dose TBI as a Preparative Regimen for Children With AML/MDS Undergoing Allo HCT Status COMPLETED Phase PHASE2
NCT01696461 A Phase II Study Evaluating the Safety and Efficacy of Subcutaneous Plerixafor Status COMPLETED Phase PHASE2
NCT01385787 MRD Testing Before and After Hematopoietic Cell Transplantation for Pediatric Acute Myeloid Leukemia Status COMPLETED Phase N/A
NCT01353677 Feasibility of Collecting Quality of Life Data in Collaboration With the Stem Cell Therapeutic Outcomes Database Status COMPLETED Phase N/A
NCT01351545 A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs) Status RECRUITING Phase N/A
NCT00948090 PK-directed Dose Adjustment of IV Busulfan Conditioning Regimen for Autologous Stem Cell Transplant in Lymphoma Patients Status COMPLETED Phase PHASE2
NCT00847639 Safety Study of Lenalidomide Maintenance Therapy Post Allogeneic HCT for High-risk Multiple Myeloma Status COMPLETED Phase PHASE2
NCT00795054 The Financial Impact of Allogeneic Stem Cell Transplantation on Patient and Family Status COMPLETED Phase N/A
NCT00785525 Filgrastim-Mobilized Stem Cells for Transplantation Using Unrelated Donors Status RECRUITING Phase PHASE3
NCT00392782 Donor Stem Cell Transplant in Treating Patients With Myeloid Cancer or Other Disease Status TERMINATED Phase PHASE2
NCT00318110 Matched Unrelated Donor Transplant for Metastatic Renal Cell Carcinoma Status TERMINATED Phase PHASE2